Information for media and journalists

Thank you for taking an interest in the story of Worldwide Cancer Research and the innovative discovery research we fund.

What do we offer to media?

We would be delighted to work with you to provide exclusive access to some of the most pioneering discovery research in the world, interviews with cancer experts, and access to cancer journey stories and unique fundraising case studies.

Email our Press team

Our spokespeople:

Dr Helen Rippon, Chief Executive

Dr Rippon has been CEO of Worldwide Cancer Research for nearly a decade, leading in that time a complete transformation of the charity to more effectively fulfil its mission: backing bold, new curestarting cancer research ideas around the world .

Her career began however as a working scientist. Following a PhD for research into the molecular biology of prostate cancer, she moved to Imperial College London in 2002 as a postdoctoral research fellow. There she joined what was at that time the only research group in the world studying the use of embryonic stem cells for lung repair, and co-authored some of the earliest scientific papers on the topic.

Moving to the third sector in 2008 brought a broader, more strategic perspective on medical research. Dr Rippon oversaw the funding programmes of Age UK and Prostate Cancer UK before moving to Worldwide Cancer Research as Director of Research in 2012. Here she took the reins of a grant funding programme that has to date invested more than £200 million into discovery cancer research across 35 countries.

Outside her executive role, Helen combines her scientific background with a personal passion for endurance running as a NED at the Chartered Association for Sports & Exercise Sciences. She is also a recipient of Meyler Campbell’s prestigious John Stopford Scholarship, allowing her gain accreditation as an executive coach and support other senior leaders.

Dr Rippon can be found talking science and running on Instagram and Threads @dr.helenrippon.

The strides we are making gives us a real cause for optimism, there is still a way to go, but we’re taking so many positive steps in cancer research, treatment, prevention and diagnosis. This is thanks to an increase in our understanding of cancer, which has been made possible by the discovery research we fund and the amazing Curestarters who support this work.

Dr Helen Rippon Chief Executive

Chair of our Scientific Advisory Committee
Dr Olivia Rossanese

Dr Olivia Rossanese is a cancer biologist at The Institute of Cancer Research and a drug discovery professional and has contributed to the discoveries of several cancer drugs. Dr Rossanese is the current Chair of our Scientific Advisory Committee – the group of experts who help select the most innovative, high-quality research projects we fund.
Director of Fundraising
Laura Brady

Laura Bradyis responsible for raising the charity’s profile, as well as a wide-ranging portfolio of fundraising. Before joining Worldwide Cancer Research, she worked in education marketing. Laura has a law degree from the University of Glasgow and a masters in journalism from Strathclyde University and spent her early career in journalism and publishing.
For all media enquiries, please contact us on 0300 777 7910 or by email.

Email our Press team